ASCP 2019 Novel Med May Curb Obsessions in Binge Eating Disorder The novel dopamine/norepinephrine reuptake inhibitor dasotraline reduces number of binge-eating days, as well as obsessions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results